An AI Scientist Proposed an ADHD Treatment on the Blockchain: BIO Price Surges

By: crypto insight|2026/04/17 11:00:10
0
Share
copy

Key Takeaways:

  • Bio Protocol’s crypto has soared 90% following a $6.9M funding boost for its AI-native platform, Bio V2.
  • The funding was led by Maelstrom Fund and aims to facilitate onchain fundraising and autonomous AI co-scientists.
  • Bio Protocol’s scientific proposal for an ADHD treatment targeting orexin receptors drove excitement in crypto-science circles.
  • BIO’s recent price spike of 40% from a low-liquidity range highlights volatility in DeSci investments.
  • LiquidChain is developing cross-chain infrastructure to support emerging DeSci and DeFi applications.

WEEX Crypto News, 2026-04-17 07:14:58

Decentralized Science and BIO Crypto’s Surge

Bio Protocol crypto recently experienced a staggering 90% price increase, catalyzed by substantial funding advancements and innovative AI applications. With a $6.9 million financial injection from Maelstrom Fund, Bio V2—a full-stack AI-native platform—was positioned at the forefront, promising onchain fundraising capabilities and AI-driven co-scientists, known as BioAgents. This development is a significant step forward in decentralized science (DeSci), capturing the focus of traders and scientists alike.

The spotlight shone further as Bio Protocol’s scientific team proposed a peptide targeting ADHD, sparking interest across crypto-science communities. Studies have shown that ADHD patients have lower levels of orexin-A/B, key in regulating arousal and attention. While existing treatments suppress orexin activity, Bio Protocol and @peptai_ have developed a peptide labeled OX2R-004, aiming to activate the OX2R receptor—potentially redefining ADHD treatment.

Can Bio Protocol Maintain Its Bullish Momentum?

Bio Protocol’s bold 40% price surge emerged from a low-liquidity environment, typifying DeSci’s high volatility. This sudden leap, while exciting, lacked a firm technical foundation, leading to questions about whether the spike can be sustained or will retract. Such moves are often followed by a period of consolidation or a partial pullback, determined by the balance between hype-driven interests and tangible utility.

Currently, BIO finds itself at an intersection between heightened interest and practical utility. To ensure a lasting price escalation, demand must translate into real-world usage, sustaining momentum as the narrative surpasses mere speculation. However, if Bio V2 fails to deliver measurable impact, the price may revert to its pre-announcement level. The broader crypto market also plays a role; downward trends in related tokens could influence BIO, potentially triggering a broader decline.

The Role of LiquidChain in DeSci’s Growth

LiquidChain has emerged as a potential game-changer in bridging the gap between decentralized science and decentralized finance applications. It’s constructing a Layer 3 protocol that combines Bitcoin’s financial strength, Ethereum’s DeFi capabilities, and Solana’s execution speed into a single, cohesive liquidity environment, without the need for asset wrapping. This innovation is key to supporting multi-chain DeSci initiatives.

LiquidChain’s architecture enables developers to create applications once and tap into user bases across multiple ecosystems—an attractive proposition for DeSci and DeFi projects. As of now, $674,947.04 has been raised in its presale, with tokens priced at $0.0145. However, presales harbor risks; success hinges on broader adoption rates, while premature entries have diminishing returns once catalysts are publicly realized.

-- Price

--

FAQ Section

What caused Bio Protocol’s price to surge by 90%?

Bio Protocol’s price increased due to a $6.9 million funding round for its AI-native platform, Bio V2, backed by Maelstrom Fund. This elevated efforts for onchain fundraising and the involvement of AI co-scientists, attracting significant interest.

Is Bio Protocol’s ADHD treatment scientifically promising?

Bio Protocol’s ADHD treatment focuses on activating the OX2R receptor with a peptide, OX2R-004. This contrasts current treatments which suppress orexin activity, offering a scientifically provocative approach to ADHD.

Can Bio Protocol sustain its current price level?

To maintain its price, Bio Protocol needs continuous demand linked to practical usage and proven utility of its platform. Hype alone can cause the price to revert once interest wanes.

What does LiquidChain offer to DeSci and DeFi projects?

LiquidChain facilitates a unified liquidity environment across blockchain ecosystems—Bitcoin, Ethereum, and Solana—thereby supporting DeSci and DeFi applications through its deploy-once framework without asset wrapping.

Are there risks associated with investing in LiquidChain’s presale?

LiquidChain’s presale carries risks, particularly due to adoption uncertainties. The potential for low initial market listings and reliance on sustained infrastructure integration poses investment challenges.

You may also like

Former ByteDance employee's account: How I started with two Pinduoduo hard drives and made six times the profit with Seagate to achieve financial freedom?

A programmer from a big tech company bought hard drives on Pinduoduo and, following clues, managed to accurately capture the sixfold rising stock Seagate using the "finding daily anomalies + 13F institutional verification" framework, making a wild profit of $400,000 and achieving financial freedom.

MiCA reshuffle begins, Binance temporarily bids farewell to the EU

What Binance leaves behind is not scattered retail investors, but a whole batch of high-value users who are forced to liquidate and have almost nowhere to go.

How does Gate redo "buying and selling stocks" from the cryptocurrency world to the stock market?

The competition logic of exchanges has changed.

Visa and Mastercard join 140 giants to launch a new stablecoin, but the impact on the market landscape may still be limited

As an important milestone event in the stablecoin landscape, OUSD is likely to change the existing stablecoin landscape and significantly increase the adoption rate of stablecoins in the global financial system.

Circle CEO responds to OUSD's challenge: Stablecoins are a winner-takes-all business, and we will not slow down

OUSD was jointly launched by more than 140 giants, causing Circle's stock price to plummet in a single day. Circle's CEO personally wrote a response, clarifying USDC's moat from three aspects: network effects, liquidity, and regulation, and dismantling OUSD's three selling points of "free redemption...

Argentina vs Cape Verde: When a Record-Breaking Legend Meets an Unbreakable Underdog

WEEX exclusive pre-match analysis of Argentina vs Cape Verde, exploring Messi-led Argentina’s dominance and Cape Verde’s historic defensive breakout, with a breakdown of volatility, structure, and match dynamics.

Popular coins

Latest Crypto News

Read more
iconiconiconiconiconiconicon
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Program:support@weex.com